VALBIOTIS (EPA:ALVAL) | WebDisclosure

Basculer en Français

9796	Companies
196331	Keywords
127365	Articles
104395	Press releases

Home
Companies
VALBIOTIS

PRESS RELEASE

published on 01/30/2025 at 17:40, 1 year ago

VALBIOTIS SA: Valbiotis commercialisera dès le 3 février prochain sa solution Valbiotis®PRO Santé métabolique (Totum•63) pour la prévention des maladies métaboliques
Valbiotis SA va commercialiser Valbiotis®PRO Santé métabolique (Totum•63) pour la prévention des maladies métaboliques à partir du 3 février, basée sur TOTUM•63 et stratégie multicanal

Valbiotis SA TOTUM•63 Valbiotis®PRO Santé Métabolique Prévention Maladies Métaboliques Stratégie Multicanal
BRIEF

published on 01/21/2025 at 17:45, 1 year ago

Valbiotis Outlines 2030 Strategic and Financial Targets

Financial Targets Valbiotis International Sales 2030 Goals Cardiometabolic
BRIEF

published on 01/21/2025 at 17:45, 1 year ago

Valbiotis présente ses objectifs stratégiques et financiers à horizon 2030

Objectifs Financiers Valbiotis Ventes Internationales Objectifs 2030 Cardiométabolique
PRESS RELEASE

published on 01/21/2025 at 17:40, 1 year ago

VALBIOTIS SA: Valbiotis unveils its strategic and financial goals for 2030
Valbiotis unveils its strategic and financial goals for 2030, focusing on product releases, turnover targets, and international sales expansion. Detailed roadmap and value proposition presented

Valbiotis Strategic Goals International Sales Financial Goals Product Releases
PRESS RELEASE

published on 01/21/2025 at 17:40, 1 year ago

VALBIOTIS SA: Valbiotis dévoile ses ambitions stratégiques et financières à horizon 2030
Valbiotis dévoile ses ambitions stratégiques et financières à horizon 2030 avec trois produits pour la prise en charge des troubles cardio-métaboliques sur le marché en France dès 2025

Commercialisation Valbiotis Ambitions Stratégiques Financières Cardio-métaboliques
BRIEF

published on 01/14/2025 at 17:49, 1 year ago

Valbiotis Announces Success in HEART II Study on Lipidrive

Valbiotis Lipidrive Hypercholesterolemia HEART II Study LDL Cholesterol
BRIEF

published on 01/14/2025 at 17:49, 1 year ago

Valbiotis annonce le succès de l'étude HEART II sur Lipidrive

Valbiotis Cholestérol LDL Hypercholestérolémie Lipidrive Étude HEART II
PRESS RELEASE

published on 01/14/2025 at 17:45, 1 year ago

VALBIOTIS SA: Valbiotis annonce le large succès de l’étude clinique de phase II/III HEART II sur LIPIDRIVE
Valbiotis annonce le succès de l'étude clinique de phase II/III HEART II sur Lipidrive. Efficacité prouvée sur la réduction du LDL Cholestérol chez individus avec hypercholestérolémie légère à modérée

Valbiotis Étude Clinique Santé Cardiovasculaire Hypercholestérolémie LDL Cholesterol
PRESS RELEASE

published on 01/14/2025 at 17:44, 1 year ago

VALBIOTIS SA: Valbiotis announces the major success of the phase II/III HEART II clinical study on LIPIDRIVE
Valbiotis announces success of phase II/III HEART II study on LIPIDRIVE, proving efficacy in reducing LDL cholesterol for mild to moderate hypercholesterolemia. Study validates safety & compliance of Lipidrive

Valbiotis Lipidrive Hypercholesterolemia HEART II Study LDL Cholesterol
PRESS RELEASE

published on 01/14/2025 at 17:44, 1 year ago

VALBIOTIS SA: Valbiotis annonce le large succès de l’étude clinique de phase II/III HEART II sur LIPIDRIVE
Valbiotis annonce le large succès de l'étude clinique de phase II/III HEART II sur LIPIDRIVE, démontrant l'efficacité sur la réduction du LDL Cholestérol. L'étude confirme l'approche scientifique innovante de Valbiotis

Valbiotis Santé Efficacité Étude Clinique LDL Cholesterol

Accesswire

Published on 02/03/2026 at 15:00, 5 hours 43 minutes ago

Vox Royalty Announces Record 2025 Annual and Quarterly Receipts and Exceeds Annual Guidance
Published on 02/03/2026 at 14:29, 6 hours 14 minutes ago

Worksport Ltd. Announces Strategic Partnership With Potomac International Partners to Accelerate Federal Government and Commercial Market Adoption of Clean Energy Ecosystem
Published on 02/03/2026 at 13:58, 6 hours 45 minutes ago

QNX and Haleytek Join Forces to Deliver Software-Defined Audio for Volvo Cars' EX60 EV SUV
Published on 02/03/2026 at 13:30, 7 hours 13 minutes ago

Alset AI's Lyken.AI Secures Cloud Compute Services Purchase Order from Leading Multinational Technology and Telecommunications Company
Published on 02/03/2026 at 13:30, 7 hours 13 minutes ago

Lahontan Selects RESPEC and Kappes Cassiday to Update Santa Fe Mineral Resource Estimate and PEA

View all ACCESSWIRE

EQS Group

Published on 02/03/2026 at 20:36, 6 minutes ago

Freelance.com: Agenda de communication financière 2026-2027
Published on 02/03/2026 at 20:05, 38 minutes ago

KHUFU'S IN EGYPT NAMED NO.1 AT MIDDLE EAST & NORTH AFRICA'S 50 BEST RESTAURANTS 2026
Published on 02/03/2026 at 19:52, 50 minutes ago

POS-Transaction in Own Shares
Published on 02/03/2026 at 19:50, 53 minutes ago

Blockchain.com & Ondo Finance Launch Onchain Tokenized U.S. Stocks Across Europe
Published on 02/03/2026 at 19:44, 58 minutes ago

learnd Continues Growth Trajectory with Acquisition of Safe & Sound Control Systems

Les Echos

Published on 02/03/2026 at 19:18, 1 hour 24 minutes ago

Paulic Meunerie - Chiffre d'Affaires 2025
Published on 02/03/2026 at 18:00, 2 hours 43 minutes ago

Mint dépasse ses ambitions annoncées pour 2025 grâce à des succès commerciaux majeurs dans le BtoB
Published on 02/03/2026 at 17:45, 2 hours 58 minutes ago

Informations relatives au nombre total de droits de vote et d’actions
Published on 02/03/2026 at 17:45, 2 hours 58 minutes ago

Revenue growth in 2025 to €11.2m (+5%)
Published on 02/03/2026 at 17:45, 2 hours 58 minutes ago

Chiffre d’affaires 2025 en croissance à 11,2 M€ (+5%)

View all LES ECHOS COMFI WIRE